Evidence map›Paper›PMID 30515165›Full record

Trial reportFrontiers in immunology2018

Dysregulated miR-155 and miR-125b Are Related to Impaired B-cell Responses in Down Syndrome.

Chiara Farroni, Emiliano Marasco, Valentina Marcellini, Ezio Giorda, Diletta Valentini, Stefania Petrini, Valentina D'Oria, Marco Pezzullo, Simona Cascioli, Marco Scarsella and 4 more

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Role of miR-155 in inflammatory autoimmune diseases: a comprehensive review.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Pooled it
  2. Observational
  3. Review
  4. Review
  5. Observational
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Natural Products Treat Colorectal Cancer by Regulating miRNA.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. miR-155: An Important Role in Inflammation Response.Journal of immunology research · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Chiara FarroniB cell Pathophysiology Unit, Immunology Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Emiliano MarascoDivision of Rheumatology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Valentina MarcelliniResearch Laboratories, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Ezio GiordaResearch Laboratories, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Diletta ValentiniPediatric and Infectious Disease Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Stefania PetriniResearch Laboratories, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Valentina D'OriaResearch Laboratories, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Marco PezzulloResearch Laboratories, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Simona CascioliB cell Pathophysiology Unit, Immunology Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Marco ScarsellaResearch Laboratories, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Alberto G UgazioInstitute of Child and Adolescent Health, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Giovanni C De VincentiisUnit of Otolaryngology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Ola GrimsholmB cell Pathophysiology Unit, Immunology Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Rita CarsettiB cell Pathophysiology Unit, Immunology Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Istituti di Ricovero e Cura a Carattere Scientifico · ITBambino Gesù Children's Hospital · ITUniversity of Gothenburg · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Children with Down Syndrome (DS) suffer from immune deficiency with a severe reduction in switched memory B cells (MBCs) and poor response to vaccination. Chromosome 21 (HSA21) encodes two microRNAs (miRs), miR-125b, and miR-155, that regulate B-cell responses. We studied B- and T- cell subpopulations in tonsils of DS and age-matched healthy donors (HD) and found that the germinal center (GC) reaction was impaired in DS. GC size, numbers of GC B cells and Follicular Helper T cells (T

Indexed as

Immunologic MemoryB-LymphocytesDown SyndromeFemaleHumansMaleMicroRNAsMicroRNAsMIRN125 microRNA, humanMIRN155 microRNA, humanantagomiRB cellDown Syndromegerminal centerimmunodeficiencymiR-125bmiR-155plasma cells

Identifiers

PMID30515165
PMCPMC6255899
OpenAlexW2900825677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.